Advertisement

February 19, 2020

Viz.ai Launches Next-Generation Artificial Intelligence Synchronized Care Platform for Stroke

February 19, 2020—Viz.ai, a company focused on applied artificial intelligence in health care, launched the next generation of its synchronized care platform for stroke. The company introduced the platform at the International Stroke Conference, held February 18–21 in Los Angeles, California.

According to the company, the Viz.ai platform incorporates cutting-edge artificial intelligence with HIPAA-compliant communication to allow stroke teams to quickly and efficiently triage patients to time-sensitive care with the aim of reducing time to treatment and increasing access to endovascular intervention.

New capabilities allow the stroke care team to synchronize care from stroke code notification to the postacute care period. Expanded functionality will empower the stroke team with quick, relevant, clinical and imaging information to support faster diagnosis and treatment decisions.

The company stated that the device’s innovations include enhanced communication capabilities, expanded image viewing and analysis, enhanced security, electronic health record system integration, and Viz Analytics—a robust business intelligence dashboard—to help neuroscience administrators with stroke service line planning and collection of quality improvement metrics to support the requirements for Joint Commission and DNV certification.

In Viz.ai’s announcement, Johanna T. Fifi, MD, commented, “Artificial Intelligence has revolutionized acute stroke care. This platform has transformed our ability to treat cerebrovascular patients and is an integral part of our stroke workflow.” Dr. Fifi is Associate Professor of Neurosurgery and Neurology, Icahn School of Medicine at Mount Sinai, and Associate Director of the Cerebrovascular Center at the Mount Sinai Health System in New York, New York.

Advertisement


February 20, 2020

Effect of Time of Presentation on Endovascular Treatment Decisions in Acute Stroke Patients

February 18, 2020

Japanese Study Supports EVAR for Ruptured AAA in Octogenarian Patients With Suitable Anatomy